Revalor® S

A growth promotant with slow release of active principle which induces the increased laying down of lean meat without increasing fat deposition.

FOR ANIMAL USE ONLY

REVALOR® S

Reg. No. G2024 (Act 36/1947)

Implant for use in cattle only

INDICATIONS

Revalor® S is a slow-release growth promotant containing trenbolone acetate and oestradiol which induces increased laying down of lean meat without increasing fat deposition. Therefore, it improves feed conversion and mass gain. The active principles have short half-lives on release into the plasma, obviating carcass residue problems.

COMPOSITION

Each implant contains 140 mg of trenbolone acetate and 28 mg 17ß-oestradiol.

Each implant consists of 7 pellets, each containing 20 mg trenbolone acetate and 4 mg 17ß-oestradiol.

STORAGE INSTRUCTIONS

  • Store unopened Revalor® S at or below 25 °C in the original packaging.
  • Avoid excessive heat and humidity.
  • Use Revalor® S before the expiry date stated on the label.

WARNINGS

  • Withdrawal period: No withdrawal period is required when used according to the label.
  • DO NOT USE IN ANIMALS INTENDED FOR BREEDING PURPOSES.
  • ONLY FOR USE IN BULLS, STEERS AND HEIFERS IN FEEDLOTS.
  • Handle Revalor® S with care, as it is harmful if swallowed.
  • Implant pellets subcutaneously in the back of the ear only.
  • Do not use implant site for human or animal consumption.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Store away from food and feed.
  • Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
  • Do not contaminate rivers, dams or any water sources with implants or waste.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

Dosage and administration

The multiple dose cartridge consists of 10 implants, each containing 7 small pellets. A single implant is placed under the skin, on the posterior aspect of the ear (Fig. 1), by means of a special implanter. The implanter is available from Intervet South Africa (Pty) Ltd. (refer to implanter instructions).

Site of implantation

After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site with a suitable sanitiser.

The site of implantation is the soft skin on the posterior aspect of the ear.

The implant should be placed as far from the head as possible without inserting the implanter needle into the area where the skin is firmly attached to the cartilage.

THE IMPLANT MUST NOT BE PLACED CLOSER TO THE HEAD THAN THE EDGE OF THE CARTILAGE RING FARTHEST FROM THE HEAD.

The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site (Fig. 2).

Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.

Fig. 1 – Ear of bovine ready for implantation
Fig. 2 – Rear view of the bovine ear showing the site for insertion of the implanter needle

PRESENTATION

Each implant consists of 7 small pellets.

20 doses in 2 cartridges with 10 implants per cartridge, packed in a cardboard box.

100 doses in 10 cartridges with 10 implants per cartridge, packed in a cardboard box.

500 doses in 50 cartridges with 10 implants per cartridge, packed in a cardboard box.

Not all pack sizes may necessarily be marketed.

REGISTRATION HOLDER

Intervet South Africa (Pty) Ltd.

20 Spartan Road, Spartan

1619, RSA

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

02 March 2007